AN2 Therapeutics

IPO

Developing Therapies for Rare, Chronic, and Serious Infectious Diseases

Public · Menlo Park, United States · Founded 2017 · $52.0M raised

Headquarters
Menlo Park
Founded
2017
Business Model
B2B
Total Funding
$52.0M
Last Round
$40.0M Private EquityMar 2026
Rounds
2
Type
Public

About

AN2 Therapeutics is a clinical-stage biopharmaceutical company (Nasdaq: ANTX) focused on the discovery, development, and commercialization of novel medicines for rare, chronic, and serious infectious diseases with significant unmet patient need. The founding team has a track record of pairing strategic partnerships and non-dilutive funding to advance global public health programs alongside its core clinical pipeline. AN2 is headquartered in Menlo Park, California.

Summary

AN2 Therapeutics is a Biotech company based in Menlo Park, United States, founded in 2017. It has raised $52.0M in total across 2 rounds, most recently a $40.0M Private Equity round in Mar 2026. Investors include Mountain Partners, Coastlands Capital and Commodore Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityMar 2026
$40.0M

Sign up to see all 3 rounds

Series A through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AN2 Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/an2-therapeutics"><img src="https://indexed.vc/api/badge/company/an2-therapeutics" alt="AN2 Therapeutics on Indexed.vc" width="260" height="76" /></a>